Mercator Medical S.A. - Asset Resilience Ratio
Mercator Medical S.A. (MRC) has an Asset Resilience Ratio of 7.15% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Mercator Medical S.A.'s Asset Resilience Ratio has changed over time. Check Mercator Medical S.A. strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Mercator Medical S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MRC market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0% |
| Short-term Investments | zł71.81 Million | 7.15% |
| Total Liquid Assets | zł71.81 Million | 7.15% |
Asset Resilience Insights
- Limited Liquidity: Mercator Medical S.A. maintains only 7.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Mercator Medical S.A. Industry Peers by Asset Resilience Ratio
Compare Mercator Medical S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 4.32% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for Mercator Medical S.A. (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Mercator Medical S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 12.17% | zł126.96 Million ≈ $34.94 Million |
zł1.04 Billion ≈ $287.17 Million |
+0.82pp |
| 2023-12-31 | 11.35% | zł109.53 Million ≈ $30.14 Million |
zł965.23 Million ≈ $265.64 Million |
-6.98pp |
| 2022-12-31 | 18.32% | zł198.46 Million ≈ $54.62 Million |
zł1.08 Billion ≈ $298.08 Million |
+3.14pp |
| 2021-12-31 | 15.19% | zł195.69 Million ≈ $53.86 Million |
zł1.29 Billion ≈ $354.62 Million |
+3.76pp |
| 2020-12-31 | 11.43% | zł147.32 Million ≈ $40.54 Million |
zł1.29 Billion ≈ $354.84 Million |
-- |
About Mercator Medical S.A.
Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and household and… Read more